Federal Supply Schedule 36F79723D006E

Award Date 12/1/22
Last Date to Order 5/30/23
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business. The FSS contract, under Federal Supply Class 65 I B, provides for the delivery of pharmaceutical and hematology-related products to VA facilities nationwide, with a ceiling value of $225,000 and a period of performance through May 2028. Additionally, Nobelpharma America, LLC was awarded a...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Boehringer Ingelheim Pharmaceuticals Inc. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products, with a ceiling value of $5,020,461,140.00. The period of performance extends from the award date of September 15, 2022, to the ultimate completion date of September 14, 2027. As a multiple award FSS contract, this vehicle allows the VA and...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract has a ceiling value of $419,690.00 and a period of performance ending on September 1, 2027. The prime contractor is Altathera Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The purpose of this FSS contract is to provide the VA VISN 12 with "Drugs,...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Redhill Biopharma, Inc., a for-profit pharmaceutical manufacturer. The contract is classified under the FSS-61-IB Pharmaceuticals and Drugs schedule, with a contract ceiling value of $225,000.00 and a period of performance from September 15, 2020 to September 14, 2026. The purpose of this FSS contract is to provide the VA and other federal agencies access to a range of...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract (36F79723D0079) to Fennec Pharmaceuticals, Inc., a foreign-owned, for-profit pharmaceutical company. This multiple-award contract has a ceiling value of $1,500,000 and a period of performance through February 29, 2028. It covers the provision of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB, intended to ensure VA medical centers and...
The federal contract IDV award is for a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for "65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS." The prime contractor is Kamada Inc., a foreign-owned for-profit organization. The contract has a ceiling value of $750,000.00 and a period of performance from July 1, 2024 to June 30, 2029. The contract was awarded without any set-asides and is a multiple award. As an FSS contract, it...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV is a multiple-award Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Vanda Pharmaceuticals Inc. (Vanda), a for-profit pharmaceutical manufacturer. The FSS contract (36F79724D0191) has a ceiling value of $16,131,060.00 and covers the procurement of drugs, pharmaceuticals, and hematology-related products, with a period of performance through August 31, 2029. Vanda has also been awarded two single-award Blanket Purchase...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs to Day One Biopharmaceuticals, Inc. The contract has a ceiling value of $225,000.00 and a period of performance through December 6, 2029. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under FSS Category 65 I B. As a multiple award FSS contract, it allows the VA and other federal agencies to procure these medical products and...
  • 36F79723D006E
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

The federal contract IDV is a Federal Supply Schedule (FSS) contract (36F79723D006E) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 to Fennec Pharmaceuticals, Inc. The contract is an interim agreement under FSS Schedule 65 IB, which covers drugs, pharmaceuticals, and hematology-related products, with a ceiling value of $25,000 and a period of performance through May 30, 2023. This IDV supports the VA's objective of providing veterans with timely access to needed medical treatments and therapies, particularly in the areas of pharmaceuticals and hematology-related products. Fennec Pharmaceuticals, a foreign-owned, for-profit pharmaceutical company, specializes in developing and commercializing innovative treatments, with a focus on addressing unmet medical needs in the field of oncology and supportive care. The company holds a second FSS contract (36F79723D0079) with the VA, with a higher ceiling value of $1,500,000 and a longer period of performance through February 29, 2028, also under Schedule 65 IB. These IDVs ensure VA medical centers and clinics have reliable access to the necessary pharmaceutical and hematology-related products to support the health and well-being of veterans.

Generated 2/11/25, 10:08 AM